Gene therapy and liver metastases;Therapie genique et metastases hepatiques

Schweizerische Medizinische Wochenschrift

Volumn 129, Issue 34, 1999, Pages 1187-1195

  Martinet, O ^a,b   Reis, E D ^a   Gillet, M ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cancer; Gene therapy; Liver; Metastases

Indexed keywords

ANTINEOPLASTIC ACTIVITY; CANCER SURVIVAL; COLORECTAL CANCER; GENE THERAPY; HUMAN; LIVER METASTASIS; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; COLORECTAL TUMOR; GENE VECTOR; LIVER TUMOR; METASTASIS; METHODOLOGY;

COLORECTAL NEOPLASMS; GENE THERAPY; GENETIC VECTORS; HUMANS; LIVER NEOPLASMS;

EID: 0033612791     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Steele G Jr, Ravikumar TS, Resection of hepatic metastases from colorectal cancer: biologic perspectives. Ann Surg 1989;210:127-38.
2. Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma verified by laparotomy. Cancer 1969;23:198-202.
3. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995;19:71-89.
4. Blaese RM, Culver KM, Miller AD, Carter CS, Fleisher T, Clerici M, et al. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 1995; 270:478-80.
5. Whartenby KA, Abboud CN, Marrogi AJ, Ramesh R, Freeman SM. The biology of cancer gene therapy. Lab Invest 1995;72:131-45.
6. Hurford RK Jr, Dranoff G, Mulligan RC, Tepper RI. Gene therapy of metastatic cancer by in vivo retroviral gene targeting. Nat Gen 1995;10:430-5.
7. Ram Z, Culver KW, Oshiro EM, Viola JJ, DeVroom HL, Otto E, et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat Med 1997;3:1354-61.
8. Freeman SM, Abboud CN, Whartenby KA, Packman CH, Koeplin DS, Moolten FL. The bystander effect: tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993;53:5274-83.
9. Caruso M, Panis Y, Gagandeep S, Houssin D, Salzmann JL, Klatzmann D. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci USA 1993;90:7024-8.
10. Kwong YL, Chen SH, Kosai K, Finegold MJ, Woo SL. Adenoviral-mediated suicide gene therapy for hepatic metastases of breast cancer. Cancer Gene Ther 1996;3:339-44.
11. Block A, Chen SH, Kosai K, Finegold M, Woo SL. Adenoviral-mediated herpes simplex virus thymidine kinase gene transfer: regression of hepatic metastasis of pancreatic tumors. Pancreas 1997;15:25-34.
12. Topf N, Worgall S, Hackett NR, Crystal RG. Regional "prodrug" gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppress growth of hepatic metastasis of colon carcinoma. Gene Ther 1998;5:507-13.
13. Hall SJ, Mutchnick SF, Chen SH, Woo SL, Thompson TC. Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer. Int J Cancer 1997;70:183-7.
14. Hall SJ, Sanford MA, Atkinson G, Chen SH. Induction of potent antitumor natural killer activity by herpes simplex virus thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer. Cancer Res 1998; 58:3221-5.
15. Garrido F, Gabrera T, Lopez-Nevok MA, Ruiz-Cabello F. HLA class I antigens in human tumors. Adv Cancer Res 1995;67:155-195.
16. Bonnekoh B, Greenhalgh DA, Chen SH, Block A, Rich SS, Krieg T, et al. Ex vivo and in vivo adenovirus-mediated gene therapy strategies induce a systemic immune defense in the B16 melanoma model. J Invest Dermatol 1998;110:867-71.
17. Lode NH, Dreier T, Kiang R, Varki NM, Kang AS, Reisfeld RA. Gene therapy with a single chain interleukin-12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma. Proc Natl Acad Sci USA 1998;95:2474-80.
18. Shiratori Y, Kanai F, Hikiba Y, Moriyama H, Hamada H, Matsumuara M, et al. Gene therapy for hepatic micrometastasis of murine colon carcinoma. J Hepatol 1998; 28:886-95.
19. Chen SH, Kosai K, Xu B, Pham-Nguyen K, Contant C, Finegold MJ, et al. Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained antitumor immunity prolongs animal survival. Cancer Res 1996;56:3758-62.
20. Kwong YL, Chen SH, Kosai K, Finegold M, Woo SL. Combination therapy with suicide and cytokine genes for hepatic metastases of lung cancer. Chest 1997;112:1332-7.
21. Skuse GR, Ludlow JW. Tumor suppressor genes in disease and therapy. Lancet 1995;345:902-6.
22. Che PL, Chen Y, Bookstein R. Genetic mechanisms of tumor suppression by the human p53 gene. Science 1990;250: 1576-80.
23. Roemer K, Friedmann T. Mechanisms of action of the p53 tumor suppressor and prospects for cancer gene therapy by reconstitution of p53 function. Ann NY Acad Sci 1994;716: 265-82.
24. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J. Induction of apoptosis by wild-type p53 in human colon tumor-derived cell line. Proc Natl Acad Sci USA 1992; 89:4495-9.
25. Nielsen LL, Maneval D. P53 tumor suppressor gene therapy for cancer. Cancer Gen Ther 1998;5:52-63.
26. Nielsen LL, Gurnani M, Syed J, Dell J, Hartman B, Cartwright M, et al. Recombinant El-deleted adenovirus-mediated gene therapy for cancer: efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models. Hum Gene Ther 1998;9:681-94.
27. Lesoon-Wood LA, Kim WH, Kleinmann HK, Weintraub BD, Mixson AJ. Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice. Hum Gene Ther 1995;6:395-405.
28. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1989;82:4-6.
29. Folkman J. Angiogenesis and breast cancer. J Clin Oncol 1994;12:441-3.
30. Fidler IJ, Ellis LM. The implication of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994;79: 185-8.
31. Zetter BR. Angiogenesis and tumor metastasis. Annu Rev Med 1998;49:407-24.
32. Kong HL, Hecht D, Song W, Kovesdi I, Hackett NR, Yayon A, et al. Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor. Hum Gene Ther 1998;9:823-33.
33. Pengian L, Buxton JA, Acheson A, Radziejewski C, Maison-pierre PC, Yancopoulos GD, et al. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2. Proc Natl Acad Sci USA 1998;95:8829-34.
34. Warren RS, Yuan H, Matli MR, Gillett NA, Ferrarra N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 1995;95:1789-97.
35. Griscelli F, Li H, Bennaceur-Griscelli A, Opolon P, Soria C, Perricaudet M, et al. Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with mitosis arrest. Proc Natl Acad Sci USA 1998;95:6367-72.
36. Kirsch M, Strasser J, Allende R, Bello L, Zhang J, Black PM. Angiostatin suppresses malignant glioma growth in vivo. Cancer Res 1998;58:4654-9.
37. Vahrmeijer AL, Van Der Erb MM, Van Dierendonck JH, Kuppen PJK, Van De Velde CJH. Delivery of anticancer drugs via isolated hepatic perfusion: a promising strategy in the treatment of irresectable liver metastases ? Semin Surg Oncol 1998;14:262-8.
38. Rubin J, Galanis E, Pitot HC, Richardson RL, Burch PA, Charboneau JW, et al. Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogenic histocompatibility antigen, HLA-B7. Gene Ther 1997;4:419-25.
39. Stopeck AT, Hersh EM, Akporiaye ET, Harris DT, Grogan T, Unger E, et al. Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7 in patients with metastatic melanoma. J Clin Oncol 1997;15:341-9.
40. Sterman DH, Treat J, Litzky LA, Amin KM, Coonrod L, Molnar-Kimber K, et al. Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma. Hum Gene Ther 1998;9: 1083-92.
41. Paillard F. Cancer gene therapy Annual Conference 1997: trends and news. Hum Gene Ther 1998;9:283-6.
42. Aehischer P, Schluep M, Deglon N, Joseph JM, Hirt L, Heyd B, et al. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat Med 1996;2:996-9.
43. Bismuth H, Adam R, Lévi F, Farabos C, Waechter F, Castaing D, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996;224:509-22.